LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) Capital expenditures 2016–2025
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$452,000FY2025 · since FY2016: $1.9M → $452,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $452,000 | -75.2% |
| FY2024 | $1.8M | -48.3% |
| FY2023 | $3.5M | -80.4% |
| FY2022 | $17.9M | +104.6% |
| FY2021 | $8.8M | +96.5% |
| FY2020 | $4.5M | +74.6% |
| FY2019 | $2.6M | +187.8% |
| FY2018 | $887,000 | -58.9% |
| FY2017 | $2.2M | +16.5% |
| FY2016 | $1.9M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice